Voice biomarkers as game-changer in improving patient outcomes and reducing costs.

Voice biomarkers as game-changer in improving patient outcomes and reducing costs.

How our SaaS Platform for Voice Analysis works

We provide AI-driven technology to extract digital biomarkers from voice samples

Created in Germany
ISO-certified Infrastructure
Following ISO 13485

Why choose our Voice Biomarkers Technology?

Reliability & Accuracy

80%+ accuracy evaluated in ongoing clinical trials

High Accessibility

Voice data easily collected with smartphones

Scalability

Across languages, markets and indications

Non-invasive and cost-effective

Monitoring instrument

Data Protection

Through anonymization of patient data, encryption and secure storage

Regulatory Independence

From country-specific regulations

Would you like to take a look at our latest news?

Read now
Currently, we focus on two applications in respiratory diseases and cardiology - the biggest causes of hospitalization worldwide.

Vocal Biomarkers in Heart Failure

  • Heart’s inability to pump efficiently causes lung fluid retention that leads to voice alterations.
  • Vocal biomarkers for detecting heart failure severity state and early prediction of heart decompensation.
  • Novel data sets collected in clinical studies.
  • Dedicated patient companion app developed by Zana with patients.

Vocal Biomarkers in Respiratory Diseases

  • Voice changes are highly correlated with altered lung function in patients with asthma and COPD (Chronic obstructive pulmonary disease).
  • Vocal biomarkers for early prediction of shortness of breath and declining lung function.
  • Novel and tailored data sets collected in clinical studies.
  • Customized patient app for real-world data collection developed by Zana.

Our goal is to democratize the digital biomarkers market

Zana AI platform is designed to integrate biomarkers and speech analysis tools developed by other industry players - growing into a go-to place for digital biomarker services for various indications.